Tag: Healthcare Policy
Maryland Governor Signs Law Expanding State’s Prescription Drug Affordability Board Powers
In a pretty big deal, Maryland Gov. Wes Moore went ahead and signed this bill that lets a state board keep working on making prescription drugs cheaper for everyone in the state, not just...
Trump’s Approach to Drug Pricing Plan: What to Expect
President Trump is like totally gonna try to push this “most-favored nation” policy next week to like bring down drug prices in the U.S. It’s gonna shake things up for sure, especially for the...
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee policy. Pitts, who served as the senior official in charge...
Trump’s FDA and NIH Picks, FDA Office Crunch: Pharmalittle Update
As the week comes to a close, many of us are looking forward to some well-deserved rest and relaxation. Personally, I'm excited to spend time with loved ones, walk my furry friends, and enjoy...
RFK Jr.’s Stem Cell Deregulation Roundtable: Red Flags Raised
Renowned cell biology and human anatomy professor at UC Davis School of Medicine, Paul Knoepfler, introduces a new column, Lab Dish, focusing on regenerative medicine. The recent roundtable on regenerative medicine hosted by Health...
Suspend U.S. patents on medicines to fight U.S. tariffs
In the wake of the recent imposition of 25% tariffs on goods from Canada by the Trump administration, the Canadian government is responding with tariffs of its own. Amidst this escalating trade conflict, there...
Reforming FDA to Help Rare Disease Patients
President Donald Trump has the potential to revolutionize the landscape of rare disease treatments and save countless American lives through strategic policy changes, innovative science, and strong leadership within government agencies. This ambitious claim...
Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs
Medicare to Negotiate Prices of Diabetes and Weight Loss DrugsIn a groundbreaking move, Medicare officials have announced plans to negotiate the prices of two widely-used drugs for diabetes and weight loss. Ozempic and Wegovy,...
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has stirred a heated debate among policymakers and healthcare experts. The...
Biden’s Medicare Advantage Regulation Boosts Payments to Insurers
Biden's Medicare Advantage Regulation Boosts Payments to InsurersIn a groundbreaking move that could reshape the landscape of the Medicare Advantage industry, President Biden's Centers for Medicare and Medicaid Services recently unveiled a...
Navigating the GOP’s Healthcare Agenda: Balancing Health and Insurance
RFK Jr.'s Unconventional Stance on Health Insurance
In a surprising turn of events, Robert F. Kennedy Jr., known for his Make American Healthy Again movement, has been chosen by President Trump to lead the Department...
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...